Literature DB >> 9762088

The resolution of membrane proteins based upon size, charge, and hydrophobicity.

P B Fernandes1, R V Nardi, S G Franklin.   

Abstract

Currently available systems for resolving membrane proteins are based only on size and charge differences. Recently, it has been shown that Triton-urea-acetic acid gels which separate proteins on the basis of charge, size and hydrophobicity are capable of resolving proteins differing only by the substitution of a single neutral amino acid. We have applied this new method to the resolution of bacterial envelope proteins. Conditions for optimal resolution of different bacterial envelope proteins were determined by electrophoresis through transverse urea and Triton X-100 gradient gels. We have also correlated the components resolved in this system with those resolved by classical sodium dodecyl sulfate-gel electrophoresis by using two-dimensional slab gels combining the two systems. Furthermore, envelope protein fractions from different species and strains of bacteria were compared to identify specific proteins. This system appears to be a promising method for investigating envelope proteins which are due to missense mutations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 9762088     DOI: 10.1016/0003-2697(78)90820-5

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  3 in total

1.  Partial Purification of an Ethylene-binding Component from Plant Tissue.

Authors:  E C Sisler
Journal:  Plant Physiol       Date:  1980-09       Impact factor: 8.340

2.  Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  P B Fernandes; C Kim; K R Cundy; N N Haung
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

3.  Identification of a phosphotransferase system of Escherichia coli required for growth on N-acetylmuramic acid.

Authors:  Ulrike Dahl; Tina Jaeger; Bao Trâm Nguyen; Julia M Sattler; Christoph Mayer
Journal:  J Bacteriol       Date:  2004-04       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.